167 related articles for article (PubMed ID: 1309359)
1. Human colonic aspirates containing immunoglobulin A antibody to Clostridium difficile toxin A inhibit toxin A-receptor binding.
Kelly CP; Pothoulakis C; Orellana J; LaMont JT
Gastroenterology; 1992 Jan; 102(1):35-40. PubMed ID: 1309359
[TBL] [Abstract][Full Text] [Related]
2. Saccharomyces boulardii protease inhibits the effects of Clostridium difficile toxins A and B in human colonic mucosa.
Castagliuolo I; Riegler MF; Valenick L; LaMont JT; Pothoulakis C
Infect Immun; 1999 Jan; 67(1):302-7. PubMed ID: 9864230
[TBL] [Abstract][Full Text] [Related]
3. Binding of Clostridium difficile toxin A to human milk secretory component.
Dallas SD; Rolfe RD
J Med Microbiol; 1998 Oct; 47(10):879-88. PubMed ID: 9788811
[TBL] [Abstract][Full Text] [Related]
4. Diminished Clostridium difficile toxin A sensitivity in newborn rabbit ileum is associated with decreased toxin A receptor.
Eglow R; Pothoulakis C; Itzkowitz S; Israel EJ; O'Keane CJ; Gong D; Gao N; Xu YL; Walker WA; LaMont JT
J Clin Invest; 1992 Sep; 90(3):822-9. PubMed ID: 1325998
[TBL] [Abstract][Full Text] [Related]
5. Polymeric IgA is superior to monomeric IgA and IgG carrying the same variable domain in preventing Clostridium difficile toxin A damaging of T84 monolayers.
Stubbe H; Berdoz J; Kraehenbuhl JP; Corthésy B
J Immunol; 2000 Feb; 164(4):1952-60. PubMed ID: 10657645
[TBL] [Abstract][Full Text] [Related]
6. Immunoglobulin and non-immunoglobulin components of human milk inhibit Clostridium difficile toxin A-receptor binding.
Rolfe RD; Song W
J Med Microbiol; 1995 Jan; 42(1):10-9. PubMed ID: 7739018
[TBL] [Abstract][Full Text] [Related]
7. Asymptomatic carriage of Clostridium difficile and serum levels of IgG antibody against toxin A.
Kyne L; Warny M; Qamar A; Kelly CP
N Engl J Med; 2000 Feb; 342(6):390-7. PubMed ID: 10666429
[TBL] [Abstract][Full Text] [Related]
8. Bovine immunoglobulin concentrate-clostridium difficile retains C difficile toxin neutralising activity after passage through the human stomach and small intestine.
Warny M; Fatimi A; Bostwick EF; Laine DC; Lebel F; LaMont JT; Pothoulakis C; Kelly CP
Gut; 1999 Feb; 44(2):212-7. PubMed ID: 9895380
[TBL] [Abstract][Full Text] [Related]
9. The effects of Clostridium difficile crude toxins and toxin A on ileal and colonic loops in immune and non-immune rabbits.
Ketley JM; Mitchell TJ; Candy DC; Burdon DW; Stephen J
J Med Microbiol; 1987 Aug; 24(1):41-52. PubMed ID: 3612743
[TBL] [Abstract][Full Text] [Related]
10. Sensitive assays enable detection of serum IgG antibodies against Clostridium difficile toxin A and toxin B in healthy subjects and patients with Clostridium difficile infection.
Zhao X; Bender F; Shukla R; Kang JJ; Caro-Aguilar I; Laterza OF
Bioanalysis; 2016 Apr; 8(7):611-23. PubMed ID: 26964649
[TBL] [Abstract][Full Text] [Related]
11. Characterization of rabbit ileal receptors for Clostridium difficile toxin A. Evidence for a receptor-coupled G protein.
Pothoulakis C; LaMont JT; Eglow R; Gao N; Rubins JB; Theoharides TC; Dickey BF
J Clin Invest; 1991 Jul; 88(1):119-25. PubMed ID: 1905325
[TBL] [Abstract][Full Text] [Related]
12. Systemic and mucosal antibody responses to toxin A in patients infected with Clostridium difficile.
Johnson S; Gerding DN; Janoff EN
J Infect Dis; 1992 Dec; 166(6):1287-94. PubMed ID: 1431247
[TBL] [Abstract][Full Text] [Related]
13. Intravenous immunoglobulin therapy for severe Clostridium difficile colitis.
Salcedo J; Keates S; Pothoulakis C; Warny M; Castagliuolo I; LaMont JT; Kelly CP
Gut; 1997 Sep; 41(3):366-70. PubMed ID: 9378393
[TBL] [Abstract][Full Text] [Related]
14. Effect of antisera from Clostridium difficile-infected mice on toxin-A-induced colonic epithelial cell death signaling.
Kim DH; Lee IH; Nam ST; Nam HJ; Kang JK; Seok H; Hwang JS; Kim H
J Microbiol Biotechnol; 2014 May; 24(5):696-703. PubMed ID: 24509250
[TBL] [Abstract][Full Text] [Related]
15. A human antibody binds to alpha-galactose receptors and mimics the effects of Clostridium difficile toxin A in rat colon.
Pothoulakis C; Galili U; Castagliuolo I; Kelly CP; Nikulasson S; Dudeja PK; Brasitus TA; LaMont JT
Gastroenterology; 1996 Jun; 110(6):1704-12. PubMed ID: 8964394
[TBL] [Abstract][Full Text] [Related]
16. Saccharomyces boulardii inhibits Clostridium difficile toxin A binding and enterotoxicity in rat ileum.
Pothoulakis C; Kelly CP; Joshi MA; Gao N; O'Keane CJ; Castagliuolo I; Lamont JT
Gastroenterology; 1993 Apr; 104(4):1108-15. PubMed ID: 8462799
[TBL] [Abstract][Full Text] [Related]
17. Selective neutralization of a bacterial enterotoxin by serum immunoglobulin A in response to mucosal disease.
Johnson S; Sypura WD; Gerding DN; Ewing SL; Janoff EN
Infect Immun; 1995 Aug; 63(8):3166-73. PubMed ID: 7622244
[TBL] [Abstract][Full Text] [Related]
18. Treatment with intravenously administered gamma globulin of chronic relapsing colitis induced by Clostridium difficile toxin.
Leung DY; Kelly CP; Boguniewicz M; Pothoulakis C; LaMont JT; Flores A
J Pediatr; 1991 Apr; 118(4 Pt 1):633-7. PubMed ID: 1901084
[TBL] [Abstract][Full Text] [Related]
19. Anti-Clostridium difficile bovine immunoglobulin concentrate inhibits cytotoxicity and enterotoxicity of C. difficile toxins.
Kelly CP; Pothoulakis C; Vavva F; Castagliuolo I; Bostwick EF; O'Keane JC; Keates S; LaMont JT
Antimicrob Agents Chemother; 1996 Feb; 40(2):373-9. PubMed ID: 8834883
[TBL] [Abstract][Full Text] [Related]
20. Antigenicity of amino-acid sequences from Clostridium difficile toxin B.
Torres JF; Monath TP
J Med Microbiol; 1996 Jun; 44(6):464-74. PubMed ID: 8636964
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
